» Articles » PMID: 27009145

Improving the Management of Behaviour That Challenges Associated with Dementia in Care Homes: Protocol for Pharmacy-health Psychology Intervention Feasibility Study

Overview
Journal BMJ Open
Specialty General Medicine
Date 2016 Mar 25
PMID 27009145
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: The inappropriate use of antipsychotics in people with dementia for behaviour that challenges is associated with an estimated 1800 deaths annually. However, solely focusing on antipsychotics may transfer prescribing to other equally dangerous psychotropics. Little is known about the role of pharmacists in the management of psychotropics used to treat behaviours that challenge. This research aims to determine whether it is feasible to implement and measure the effectiveness of a combined pharmacy-health psychology intervention incorporating a medication review and staff training package to limit the prescription of psychotropics to manage behaviour that challenges in care home residents with dementia.

Methods/analysis: 6 care homes within the West Midlands will be recruited. People with dementia receiving medication for behaviour that challenges, or their personal consultee, will be approached regarding participation. Medication used to treat behaviour that challenges will be reviewed by the pharmacist, in collaboration with the general practitioner (GP), person with dementia and carer. The behavioural intervention consists of a training package for care home staff and GPs promoting person-centred care and treating behaviours that challenge as an expression of unmet need. The primary outcome measure is the Neuropsychiatric Inventory-Nursing Home version (NPI-NH). Other outcomes include quality of life (EQ-5D and DEMQoL), cognition (sMMSE), health economic (CSRI) and prescribed medication including whether recommendations were implemented. Outcome data will be collected at 6 weeks, and 3 and 6 months. Pretraining and post-training interviews will explore stakeholders' expectations and experiences of the intervention. Data will be used to estimate the sample size for a definitive study.

Ethics/dissemination: The project has received a favourable opinion from the East Midlands REC (15/EM/3014). If potential participants lack capacity, a personal consultee will be consulted regarding participation in line with the Mental Capacity Act. Results will be published in peer-reviewed journals and presented at conferences.

Citing Articles

Do community-based singing interventions have an impact on people living with dementia and their carers? A mixed-methods study protocol.

Polden M, Hanna K, Ward K, Ahmed F, Brown H, Holland C BMJ Open. 2023; 13(11):e076168.

PMID: 37996231 PMC: 10668143. DOI: 10.1136/bmjopen-2023-076168.


Mapping implementation strategies of evidence-based interventions for three preselected phenomena in people with dementia-a scoping review.

Rommerskirch-Manietta M, Manietta C, Purwins D, Braunwarth J, Quasdorf T, Roes M Implement Sci Commun. 2023; 4(1):104.

PMID: 37641142 PMC: 10463361. DOI: 10.1186/s43058-023-00486-4.


Measuring person-centred care in german nursing homes - exploring the construct validity of the Dementia Policy Questionnaire: a cross-sectional study of a secondary data set.

Hoffmann A, Bergmann J, Fahsold A, Muller-Widmer R, Roes M, Holle B BMC Geriatr. 2022; 22(1):914.

PMID: 36443654 PMC: 9706957. DOI: 10.1186/s12877-022-03586-3.


Preparing care home staff to manage challenging behaviours among residents living with dementia: A mixed-methods evaluation.

Campbell N, Maidment I, Randle E, Shaw R Health Psychol Open. 2022; 7(2):2055102920933065.

PMID: 35186309 PMC: 8851137. DOI: 10.1177/2055102920933065.


MEDREV (pharmacy-health psychology intervention in people living with dementia with behaviour that challenges): the feasibility of measuring clinical outcomes and costs of the intervention.

Maidment I, Barton G, Campbell N, Shaw R, Seare N, Fox C BMC Health Serv Res. 2020; 20(1):157.

PMID: 32122341 PMC: 7053151. DOI: 10.1186/s12913-020-5014-0.


References
1.
Feldman H, Gauthier S, Hecker J, Vellas B, Subbiah P, Whalen E . A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease. Neurology. 2001; 57(4):613-20. DOI: 10.1212/wnl.57.4.613. View

2.
Folstein M, Folstein S, McHugh P . "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12(3):189-98. DOI: 10.1016/0022-3956(75)90026-6. View

3.
Kelly K, Pickett W, Yiannakoulias N, Rowe B, Schopflocher D, Svenson L . Medication use and falls in community-dwelling older persons. Age Ageing. 2003; 32(5):503-9. DOI: 10.1093/ageing/afg081. View

4.
Borson S, Doane K . The impact of OBRA-87 on psychotropic drug prescribing in skilled nursing facilities. Psychiatr Serv. 1997; 48(10):1289-96. DOI: 10.1176/ps.48.10.1289. View

5.
Dalton S, Johansen C, Mellemkjaer L, Norgard B, Sorensen H, Olsen J . Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: a population-based cohort study. Arch Intern Med. 2003; 163(1):59-64. DOI: 10.1001/archinte.163.1.59. View